Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Subcutaneous administration of modified factor IX polypeptides and treatment of hemophilia B

Subcutaneous administration of modified factor IX polypeptides and treatment of hemophilia B

US Patent 11491212 · Granted Nov 8, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modified factor VII polypeptides for subcutaneous administration and on-demand t2022
Implementing write ports in register-file array cell2021
Logical map table for detecting dependency conditions between instructions havin2012
Test circuit for measuring sense amplifier and memory mismatches2007
On-chip measurement of signal state duration2006
Sense amplifier and method for making the same2006
On-chip power-on voltage initialization2006
Pulsed dynamic keeper gating2006
On-chip signal state duration measurement and adjustment2006
Measuring and correcting sense amplifier and memory mismatches using NBTI2006
On-chip PLL locked frequency determination method and system2005
Variable delay compensation for data-dependent mismatch in characteristic of opp2004